Search
for

    Glossary Kintor Pharmaceuticals

    Kintor Pharmaceuticals is a biopharmaceutical company focused on developing innovative therapies for hair loss and other dermatological conditions. It is particularly known for its research on the topical androgen receptor inhibitor, KX-826, which aims to treat androgenetic alopecia by targeting the underlying hormonal factors contributing to hair loss. The company's work is relevant to hair biology as it explores new mechanisms to combat hair thinning and promote regrowth, distinguishing itself through its commitment to addressing both male and female pattern baldness.

    Community 10 of 71

    1. Kintor Pharmaceutical’s KX-826 Shows Promising Results in Hair Loss Study Reddit · 2 May 2025
    2. Pyrilutamide ,the molecule’s true nature Community · 20 Aug 2024
    3. Target Area Hair Count (TAHC) increase comparasion of all future treatments in clinical trial phases Reddit · 21 Apr 2024
    4. Potentially Positive Pyrilutamide News Coming Reddit · 10 Mar 2026
    5. New Hair Loss Treatment from Kintor Just Hit the Market: KX-826! Reddit · 9 Jul 2024
    6. Veradermics is now public with a billion dollar market cap. Reddit · 7 Feb 2026
    7. Kintor going after Pelage? KT-215 Reddit · 30 Aug 2026
    8. Anyone in India that order Kintors KX-826? Reddit · 16 Jun 2026
    9. Kintor 0.9% , save your money friends Reddit · 23 Mar 2026
    10. Anyone immediately lose hope for gt20029 when they realised it’s developed by kintor Reddit · 23 Dec 2025
    All community results →

    Research 10 of 339

    1. Technological Advances in Anti-hair Loss and Hair Regrowth Cosmeceuticals: Mechanistic Breakthroughs and Industrial Prospects Driven by Multidisciplinary Collaborative Innovation Aesthetic Plastic Surgery · 2025
    2. Can Pension Funds Partially Manage Longevity Risk by Investing in a Longevity Megafund? Risks · 2018 · 2 citations
    3. <i>Zizyphus jujuba</i>protects against ibuprofen-induced nephrotoxicity in rats Pharmaceutical Biology · 2013 · 15 citations
    4. Characterization of minoxidil/hydroxypropyl-β-cyclodextrin inclusion complex in aqueous alginate gel useful for alopecia management: Efficacy evaluation in male rat European Journal of Pharmaceutics and Biopharmaceutics · 2017 · 19 citations
    5. Skin Structure, Physiology, and Pathology in Topical and Transdermal Drug Delivery Pharmaceutics · 2024 · 51 citations
    6. Colchicine in Managing Skin Conditions: A Systematic Review Pharmaceutics · 2022 · 21 citations
    7. Advancing Regenerative Cellular Therapies in Non-Scarring Alopecia Pharmaceutics · 2022 · 4 citations
    8. PROSPECT OF UTILIZING EXPIRED HOMOLOGOUS PLATELET CONCENTRATES AS AN ALTERNATIVE SOURCE OF GROWTH FACTORS AND CYTOKINES IN CLINICAL SETUP FOR BETTER WOUND CARE AND HEALING Asian Journal of Pharmaceutical and Clinical Research · 2024
    9. A randomized, double-blind controlled clinical study to evaluate the efficacy and safety of minoxidil topical 2% nanosuspension with aqueous base in the treatment of androgenetic alopecia areata Journal of reports in pharmaceutical sciences · 2021
    10. Protective role of Nigella sativa in chemotherapy-induced alopecia Bangladesh Journal of Pharmacology · 2017 · 2 citations
    All research results →

    Learn 2

    1. GT20029 Experimental topical drug designed to break down androgen receptors
    2. Pyrilutamide Experimental topical anti-androgen, also known as KX-826